Testing effectiveness (Phase 2)Study completedNCT00003110What this trial is testingBleomycin in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05182385What this trial is testingVenetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)Who this might be right forALL, Recurrent, Adult Goethe University 30
Early research (Phase 1)Ended earlyNCT00019708What this trial is testingGeldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNon-Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT02828358What this trial is testingAzacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementWho this might be right forAcute Leukemia of Ambiguous LineageB Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia National Cancer Institute (NCI) 78
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Large-scale testing (Phase 3)Study completedNCT01951885What this trial is testingTac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionWho this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more Case Comprehensive Cancer Center 101
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT02435849What this trial is testingStudy of Efficacy and Safety of CTL019 in Pediatric ALL PatientsWho this might be right forB-cell Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 80
Not applicableUnknownNCT05059847What this trial is testingImpact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia AdultsWho this might be right forAcute Lymphoblastic Leukemia, Adult B-Cell Hospital General de Mexico 114
Testing effectiveness (Phase 2)Looking for participantsNCT07008885What this trial is testingBCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALLWho this might be right forAcute Lymphocytic Leukemia Chinese PLA General Hospital 30
Early research (Phase 1)Study completedNCT00040950What this trial is testingBiological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT04289220What this trial is testingAnti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic LeukemiaWho this might be right forB Cell LymphomaB-cell Acute Lymphoblastic Leukemia Yan'an Affiliated Hospital of Kunming Medical University 10
Testing effectiveness (Phase 2)UnknownNCT03265106What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma SubjectsWho this might be right forRelapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood Shenzhen BinDeBio Ltd. 20
Very early researchLooking for participantsNCT07695012What this trial is testingCAR-T Cell Therapy for ALLWho this might be right forRelapsed Acute Lymphoblastic Leukemia (ALL) Dr. Zaineb Akram 10
Testing effectiveness (Phase 2)Ended earlyNCT05086315What this trial is testingFirst-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Who this might be right forAcute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more Sanofi 101
Testing effectiveness (Phase 2)Ended earlyNCT02877082What this trial is testingTacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsWho this might be right forAcute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more Emory University 5
Large-scale testing (Phase 3)Study completedNCT03476239What this trial is testingEfficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen 121
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144